WebJul 17, 2024 · Our SEC filings can be found on our website at www.zailaboratory.com and on the SEC’s website at www.sec.gov. For more information, please contact: Investor Relations: Lina Zhang +86 136 8257 6943 [email protected] . Media: Danielle Halstrom / Christine Drury / Xiaoyu Chen +1 (215) 280-3898 / +1 (317) 385-9227 / +86 … http://sam.zailaboratory.com/

China NMPA Approves NUZYRA® as a Category 1 Innovative Drug

WebOct 20, 2024 · Zai Lab (NASDAQ: ZLAB; HKEX: 9688) is a patient-focused, innovative, commercial-stage, global biopharmaceutical company focused on developing and commercializing therapies that address medical... WebZai Lab is a patient-focused, innovative, commercial-stage, global biopharmaceutical company based in China and the U.S. We are focused on bringing best-in-class and first … ecobank ghana helpline

Zai Lab Expands U.S. Operations to Join the Cambridge …

WebDec 17, 2024 · Zai Lab Limited (NASDAQ: ZLAB; HKEX: 9688) is a patient-focused, innovative, commercial-stage, global biopharmaceutical company focused on developing and commercializing therapies that address... WebOct 4, 2024 · Zai Lab (NASDAQ: ZLAB; HKEX: 9688) is an innovative, research-based, commercial-stage biopharmaceutical company focused on developing and commercializing therapies that address medical conditions... WebNov 9, 2024 · Regional strategic collaboration for TIVDAK® (tisotumab vedotin) strengthens Zai Lab’s leadership in developing and providing access to medicine to treat women’s cancer in China Strong balance sheet with a cash position of $1.12 billion Company to host a conference call and webcast on November 10, 2024, at 8:00 a.m. ET computer monitor grip mount